B. Fulton

Single centre outcomes from definitive chemo-radiotherapy and single modality radiotherapy for locally advanced oesophageal cancer.

D. Grose, A. Mcdonald, V. Maclaren, 2016, Journal of gastrointestinal oncology.

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

T. Powles, Robert J. Jones, S. Crabb, 2020, Trials.

ATLANTIS: An adaptive multi-arm phase II trial of maintenance targeted therapy after chemotherapy in patients with metastatic urothelial cancer

T. Powles, Robert J. Jones, S. Crabb, 2019 .

Genomics of lethal prostate cancer at diagnosis and castration resistance

N. Tunariu, E. Hall, Robert J. Jones, 2019, The Journal of clinical investigation.

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status

S. Short, C. Mcbain, S. Jefferies, 2017, Clinical and translational radiation oncology.